Home » Medical Devices » Gunshot Injuries Treatment Products Market

Gunshot Injuries Treatment Products Market – Growth, Future Prospects & Competitive Analysis, 2018-2026

Price: $4999

Published: | Report ID: 6801 | Report Format : PDF


Wounds inflicted by gunshots are very painful and life-threatening if not given immediate medical attention. Hemorrhage or profuse blood loss is the chief cause of mortality seen in military warfare. Rapid and effective management of hemorrhage is a lifesaving endeavor. There is currently an increase in the number of criminal violence and accidents occurring, which leads to mass killing and traumatic injury, propelling the growth of the gunshot wound injury treatment products market. Gunshot wound management is a critical procedure that involves observation, such as determining if there is a flash bleed, checking vital signs, and investigating if there is a burn to tissues, pallor, or swelling.

The Chicago Tribune, in its latest survey, has reported that each week in the United States, approximately 1,600 people are treated in trauma centers for gunshot wounds. The Brady report for 2016 states that in the United States, each year, 34,000 people die due to gunshot injuries, while 81,000 people survive. Post-World War II, the United States has been engaged in several wars in the Middle East and Afghanistan and has suffered tremendous casualties, with soldiers succumbing to gunshot wounds. In April 2014, the USFDA approved XSTAT 30, manufactured by RevMedx, Inc., a revolutionary hemostatic device that is used for the treatment of shrapnel and gunshot wounds. It consists of small groups of expanding sponges containing x-ray markers and is directly injected into the wound cavity. It temporarily creates a barrier for blood loss, providing hemostatic pressure, and is effective for 4 hours before the patient receives medical surgery.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

The global gunshot injury treatment products market is classified as follows:


    • XSTAT
    • FLORAL


  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of the Middle East and Africa

Key players identified for the global gunshot injury treatment products market include:

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

The key players set to make a mark in the global gunshot wounds market are RevMedx, Inc. and Baxter Healthcare Corporation.

This report offers the following:

  • A concise summary of the report titled “Gunshot Injuries Treatment Products Market” is as follows:
  • For the scope of the report, historical information is taken for 2016, and 2017 is considered the base year. It helps in understanding the current market trends existing in the gunshot injury treatment products market for the duration of 2016 to 2026.
  • Compound annual growth rate and market size are covered in the market assessment studies.
  • The attractive investment proposition is covered for the market segments, which are by product and geography.
  • The product portfolio segment covers critical information such as diverse products used for the management of gunshot wounds, financial information, and recent news coverage, which are covered under the company profiles section.
  • The competitive landscape is given in the scope of the report to elucidate the existing competition in the gunshot injury treatment products market.

Frequently Asked Questions:

What is the size of Gunshot Injuries Treatment Products Market?

The market for Gunshot Injuries Treatment Products is expected to reach US$ XX Bn in 2026.

What is the Gunshot Injuries Treatment Products Market CAGR?

The Gunshot Injuries Treatment Products market is expected to see significant CAGR growth over the coming years,at XX%.

What is the Forecast period considered for Gunshot Injuries Treatment Products Market?

The report is forecasted from 2018-2026.

What is the base year considered for Gunshot Injuries Treatment Products Market?

The base year of this report is 2017.

Who are the major players in this market?

RevMedx, Inc. and Baxter Healthcare Corporation. are some of the major players in the global market.

Hot And Cold Therapy Packs Market

Report ID: 7187

Digital Therapeutics Market

Report ID: 5029

Needles Market

Report ID: 41010

Microbial Contract Biomanufacturing Market

Report ID: 41008

Medical Polymers Market

Report ID: 40983

Medical Exoskeleton Market

Report ID: 40982

Medical Drones Market

Report ID: 40981

Automatic Sampling Market

Report ID: 40979

Chromatography Consumables Market

Report ID: 40751

Cryopreservation Bags and Freezing Bags Market

Report ID: 40915

Europe Medical Device Contract Manufacturing Market

Report ID: 40558

Asia Pacific Medical Device Contract Manufacturing Market

Report ID: 40560

Purchase Options

Delivery Format: Excel.
Designed for the individual purchaser.
Users located at a single corporate site or regional office.
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


+91 6232 49 3207


24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN